Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat

eLife

Volumn 6, Issue , 2017, Pages

  Harony Nicolas, Hala ^a   Kay, Maya ^b   du Hoffmann, Johann ^a   Klein, Matthew E ^c   Bozdagi Gunal, Ozlem ^a   Riad, Mohammed ^a   Daskalakis, Nikolaos P ^a   Sonar, Sankalp ^a   Castillo, Pablo E ^c   Hof, Patrick R ^a   Shapiro, Matthew L ^a   Baxter, Mark G ^a   Wagner, Shlomo ^b   Buxbaum, Joseph D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAIFA   (Israel)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; NERVE PROTEIN; SHANK3 PROTEIN, RAT;

5 CHOICE SERIAL REACTION TIME; ADULT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTEXTUAL FEAR MEMORY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELEVATED PLUS MAZE TEST; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPERIMENTAL BEHAVIORAL TEST; HABITUATION; HISTOLOGY; IMMUNOBLOTTING; MALE; MEMORY; MILK CONTENT SCORE; MOTOR COORDINATION; NERVE CELL PLASTICITY; NONHUMAN; OBJECT LOCATION MEMORY; PHELAN-MCDERMID SYNDROME; PHENOTYPE; POLYMERASE CHAIN REACTION; POSTSYNAPTIC DENSITY; RAT; RNA SEQUENCE; SCORING SYSTEM; SOCIAL BEHAVIOR; SOCIAL DISCRIMINATION; SOCIAL INTERACTION; SOCIAL RECOGNITION TEST; VESTIBULAR SYSTEM; ANIMAL; ANIMAL BEHAVIOR; CHROMOSOME 22; CHROMOSOME DELETION; CHROMOSOME DISORDER; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; PATHOLOGY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX;

ANIMALS; BEHAVIOR, ANIMAL; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 22; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; NERVE TISSUE PROTEINS; OXYTOCIN; PREFRONTAL CORTEX; RATS; SOCIAL BEHAVIOR;

EID: 85011397525     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18904     Document Type: Article

References (74)

1. Adolphs R. 2010. Conceptual challenges and directions for social neuroscience. Neuron 65:752–767. doi: 10.1016/j.neuron.2010.03.006
2. Barendse EM, Hendriks MP, Jansen JF, Backes WH, Hofman PA, Thoonen G, Kessels RP, Aldenkamp AP. 2013. Working memory deficits in high-functioning adolescents with autism spectrum disorders: neuropsychological and neuroimaging correlates. Journal of Neurodevelopmental Disorders 5:14. doi: 10.1186/1866-1955-5-14
3. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends in Neurosciences 27:370–377. doi: 10.1016/j.tins.2004.04.009
4. Ben Shalom D. 2003. Memory in autism:review and synthesis. Cortex 39:1129–1138. doi: 10.1016/S0010-9452(08)70881-5
5. Benelli A, Bertolini A, Poggioli R, Menozzi B, Basaglia R, Arletti R. 1995. Polymodal dose-response curve for oxytocin in the social recognition test. Neuropeptides 28:251–255. doi: 10.1016/0143-4179(95)90029-2
6. Bidinosti M, Botta P, Krüttner S, Proenca CC, Stoehr N, Bernhard M, Fruh I, Mueller M, Bonenfant D, Voshol H, Carbone W, Neal SJ, McTighe SM, Roma G, Dolmetsch RE, Porter JA, Caroni P, Bouwmeester T, Lüthi A, Galimberti I. 2016. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency. Science 351:1199–1203. doi: 10.1126/science.aad5487
7. Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, Collins JS, Zollino M, Visconti P, Dupont B, Tiziano D, Schroer RJ, Neri G, Stevenson RE, Gurrieri F, Schwartz CE. 2013. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. European Journal of Human Genetics 21:310–316. doi: 10.1038/ejhg.2012.175
8. Boucher J, Mayes A, Bigham S. 2012. Memory in autistic spectrum disorder. Psychological Bulletin 138:458–496. doi: 10.1037/a0026869
9. Bozdagi O, Nagy V, Kwei KT, Huntley GW. 2007. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. Journal of Neurophysiology 98:334–344. doi: 10.1152/jn.00202.2007
10. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, Yang M, Katz AM, Scattoni ML, Harris MJ, Saxena R, Silverman JL, Crawley JN, Zhou Q, Hof PR, Buxbaum JD. 2010. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Molecular Autism 1:15. doi: 10.1186/2040-2392-1-15
11. Bozdagi O, Shan W, Tanaka H, Benson DL, Huntley GW. 2000. Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation. Neuron 28: 245–259. doi: 10.1016/s0896-6273(00)00100-8
12. Bozdagi O, Tavassoli T, Buxbaum JD. 2013. Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay. Molecular Autism 4:9. doi: 10.1186/2040-2392-4-9
13. Brownstein MJ, Russell JT, Gainer H. 1980. Synthesis, transport, and release of posterior pituitary hormones. Science 207:373–378. doi: 10.1126/science.6153132
14. Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, Luo Clayton A, Biemans B. 2015. Comprehensive analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. PLoS One 10:e0134572. doi: 10.1371/journal.pone.0134572
15. Chang SW, Barter JW, Ebitz RB, Watson KK, Platt ML. 2012. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta). PNAS 109:959–964. doi: 10.1073/pnas.1114621109
16. Drapeau E, Dorr NP, Elder GA, Buxbaum JD. 2014. Absence of strong strain effects in behavioral analyses of Shank3-deficient mice. Disease Models & Mechanisms 7:667–681. doi: 10.1242/dmm.013821
17. Duffney LJ, Wei J, Cheng J, Liu W, Smith KR, Kittler JT, Yan Z. 2013. Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism. Journal of Neuroscience 33:15767–15778. doi: 10.1523/JNEUROSCI.1175-13.2013
18. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsäter H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, et al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics 39:25–27. doi: 10.1038/ng1933
19. Ehninger D, Silva AJ. 2009. Genetics and neuropsychiatric disorders: treatment during adulthood. Nature Medicine 15:849–850. doi: 10.1038/nm0809-849
20. Fang LY, Quan RD, Kaba H. 2008. Oxytocin facilitates the induction of long-term potentiation in the accessory olfactory bulb. Neuroscience Letters 438:133–137. doi: 10.1016/j.neulet.2007.12.070
21. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT. 2000. Social amnesia in mice lacking the oxytocin gene. Nature Genetics 25:284–288. doi: 10.1038/77040
22. Gong X, Jiang YW, Zhang X, An Y, Zhang J, Wu Y, Wang J, Sun Y, Liu Y, Gao X, Shen Y, Wu X, Qiu Z, Jin L, Wu BL, Wang H. 2012. High proportion of 22q13 deletions and SHANK3 mutations in chinese patients with intellectual disability. PLoS One 7:e34739. doi: 10.1371/journal.pone.0034739
23. Guastella AJ, Graustella AJ, MacLeod C. 2012. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Hormones and Behavior 61:410–418. doi: 10.1016/j.yhbeh.2012.01.002
24. Guastella AJ, Hickie IB. 2016. Oxytocin treatment, Circuitry, and Autism: A critical review of the literature placing Oxytocin into the Autism context. Biological Psychiatry 79:234–242. doi: 10.1016/j.biopsych.2015.06.028
25. Gur R, Tendler A, Wagner S. 2014. Long-Term social recognition memory is mediated by Oxytocin-Dependent synaptic plasticity in the medial amygdala. Biological Psychiatry 76:377–386. doi: 10.1016/j.biopsych.2014.03. 022
26. Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, et al. 2011. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. The American Journal of Human Genetics 88:306–316. doi: 10.1016/j.ajhg.2011.02.001
27. Hamilton SM, Green JR, Veeraragavan S, Yuva L, McCoy A, Wu Y, Warren J, Little L, Ji D, Cui X, Weinstein E, Paylor R. 2014. Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behavioral Neuroscience 128:103–109. doi: 10.1037/a0035988
28. Harony H, Wagner S. 2010. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neuro-Signals 18:82–97. doi: 10.1159/000321035
29. Harony-Nicolas H, De Rubeis S, Kolevzon A, Buxbaum JD. 2015. Phelan McDermid syndrome: From genetic discoveries to animal models and treatment. Journal of Child Neurology 30:1861–1870. doi: 10.1177/0883073815600872
30. Harvey PO, Lepage M. 2014. Neural correlates of recognition memory of social information in people with schizophrenia. Journal of Psychiatry & Neuroscience 39:97–109. doi: 10.1503/jpn.130007
31. Jacobs SA, Tsien JZ. 2014. Overexpression of the NR2A subunit in the forebrain impairs long-term social recognition and non-social olfactory memory. Genes, Brain and Behavior 13:376–384. doi: 10.1111/gbb.12123
32. Jones MW, Wilson MA. 2005. Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task. PLoS Biology 3:e402. doi: 10.1371/journal.pbio.0030402
33. Klein ME, Castillo PE, Jordan BA. 2015. Coordination between translation and degradation regulates inducibility of mGluR-LTD. Cell Reports 10:1459–1466. doi: 10.1016/j.celrep.2015.02.020
34. Kloth AD, Badura A, Li A, Cherskov A, Connolly SG, Giovannucci A, Bangash MA, Grasselli G, Peñagarikano O, Piochon C, Tsai PT, Geschwind DH, Hansel C, Sahin M, Takumi T, Worley PF, Wang SS. 2015. Cerebellar associative sensory learning defects in five mouse autism models. eLife 4:e06085. doi: 10.7554/eLife.06085
35. Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, Rapaport R, Saland J, Srivastava S, Farrell C, Edelmann LJ, Buxbaum JD. 2014b. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. Journal of Neurodevelopmental Disorders 6:39. doi: 10. 1186/1866-1955-6-39
36. Kolevzon A, Bush L, Wang AT, Halpern D, Frank Y, Grodberg D, Rapaport R, Tavassoli T, Chaplin W, Soorya L, Buxbaum JD. 2014a. A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Molecular Autism 5:54. doi: 10.1186/2040-2392-5-54
37. Kouser M, Speed HE, Dewey CM, Reimers JM, Widman AJ, Gupta N, Liu S, Jaramillo TC, Bangash M, Xiao B, Worley PF, Powell CM. 2013. Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. Journal of Neuroscience 33:18448–18468. doi: 10.1523/JNEUROSCI.3017-13.2013
38. Kreienkamp HJ. 2008. Scaffolding proteins at the postsynaptic density: shank as the architectural framework. Handbook of Experimental Pharmacology 186:365–380. doi: 10.1007/978-3-540-72843-6_15
39. Kritman M, Maroun M. 2013. Inhibition of the PI3 kinase cascade in corticolimbic circuit: temporal and differential effects on contextual fear and extinction. The International Journal of Neuropsychopharmacology 16:825–833. doi: 10.1017/S1461145712000636
40. Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT. 2000. CEL I enzymatic mutation detection assay. BioTechniques 29:44–46
41. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 10:R25. doi: 10.1186/gb-2009-10-3-r25
42. Leblond CS, Nava C, Polge A, Gauthier J, Huguet G, Lumbroso S, Giuliano F, Stordeur C, Depienne C, Mouzat K, Pinto D, Howe J, Lemière N, Durand CM, Guibert J, Ey E, Toro R, Peyre H, Mathieu A, Amsellem F, et al. 2014. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genetics 10:e1004580. doi: 10.1371/journal.pgen.1004580
43. Li YC, Kellendonk C, Simpson EH, Kandel ER, Gao WJ. 2011. D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. PNAS 108:12107– 12112. doi: 10.1073/pnas.1109718108
44. Lin YT, Huang CC, Hsu KS. 2012. Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase Mz. Journal of Neuroscience 32:15476–15488. doi: 10.1523/JNEUROSCI.2429-12.2012
45. Lind SE. 2010. Memory and the self in autism: A review and theoretical framework. Autism 14:430–456. doi: 10.1177/1362361309358700
46. Maister L, Simons JS, Plaisted-Grant K. 2013. Executive functions are employed to process episodic and relational memories in children with autism spectrum disorders. Neuropsychology 27:615–627. doi: 10.1037/a0034492
47. Mar AC, Horner AE, Nilsson SR, Alsiö J, Kent BA, Kim CH, Holmes A, Saksida LM, Bussey TJ. 2013. The touchscreen operant platform for assessing executive function in rats and mice. Nature Protocols 8:1985–2005. doi: 10.1038/nprot.2013.123
48. Marquis JP, Goulet S, Doré FY. 2006. Neonatal lesions of the ventral hippocampus in rats lead to prefrontal cognitive deficits at two maturational stages. Neuroscience 140:759–767. doi: 10.1016/j.neuroscience.2006.02.048
49. Mei Y, Monteiro P, Zhou Y, Kim JA, Gao X, Fu Z, Feng G. 2016. Adult restoration of Shank3 expression rescues selective autistic-like phenotypes. Nature 530:481–484. doi: 10.1038/nature16971
50. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW. 2007. Contribution of SHANK3 mutations to autism spectrum disorder. The American Journal of Human Genetics 81:1289–1297. doi: 10.1086/522590
51. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. 2004. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes, Brain and Behavior 3:287–302. doi: 10.1111/j.1601-1848.2004.00076.x
52. Ninan I. 2011. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. Journal of Neurochemistry 119:324–331. doi: 10.1111/j.1471-4159.2011.07430.x
53. Parr LA, Brooks JM, Jonesteller T, Moss S, Jordano JO, Heitz TR. 2016. Effects of chronic oxytocin on attention to dynamic facial expressions in infant macaques. Psychoneuroendocrinology 74:149–157. doi: 10.1016/j.psyneuen.2016.08.028
54. Peça J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. 2011. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437–442. doi: 10.1038/nature09965
55. Peñagarikano O, Lázaro MT, Lu XH, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH. 2015. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Science Translational Medicine 7:271ra8. doi: 10.1126/scitranslmed.3010257
56. R Development Core Team. 2006. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
57. Robbins TW. 2002. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362–380. doi: 10.1007/s00213-002-1154-7
58. Rogers RD, Baunez C, Everitt BJ, Robbins TW. 2001. Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behavioral Neuroscience 115:799–811. doi: 10.1037/0735-7044.115.4.799
59. Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, Kuebler A, Janssen AL, Udvardi PT, Shiban E, Spilker C, Balschun D, Skryabin BV, Dieck S, Smalla KH, Montag D, Leblond CS, Faure P, Torquet N, Le Sourd AM, Toro R, et al. 2012. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486:256–260. doi: 10.1038/nature11015
60. Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, Frank Y, Wang AT, Cai G, Parkhomenko E, Halpern D, Grodberg D, Angarita B, Willner JP, Yang A, Canitano R, Chaplin W, Betancur C, Buxbaum JD. 2013. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Molecular Autism 4:18. doi: 10.1186/2040-2392-4-18
61. Spijker S. 2011. Dissection of rodent brain regions. Neuroproteomics. Vol 57. p 13–26. doi: 10.1007/978-1-61779-111-6_2
62. Spiteri T, Agmo A. 2009. Ovarian hormones modulate social recognition in female rats. Physiology & Behavior 98:247–250. doi: 10.1016/j.physbeh.2009.05.001
63. Tariq MA, Kim HJ, Jejelowo O, Pourmand N. 2011. Whole-transcriptome RNAseq analysis from minute amount of total RNA. Nucleic Acids Research 39:e120. doi: 10.1093/nar/gkr547
64. Tomizawa K, Iga N, Lu YF, Moriwaki A, Matsushita M, Li ST, Miyamoto O, Itano T, Matsui H. 2003. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nature Neuroscience 6:384–390. doi: 10.1038/nn1023
65. Trapnell C, Pachter L, Salzberg SL, Salzberg, TopHat SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111. doi: 10.1093/bioinformatics/btp120
66. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M. 2009. Partial reversal of rett Syndrome-like symptoms in MeCP2 mutant mice. PNAS 106:2029–2034. doi: 10.1073/pnas.0812394106
67. Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y. 2014. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 343:675–679. doi: 10.1126/science.1247190
68. Wang AT, Lim T, Jamison J, Bush L, Soorya LV, Tavassoli T, Siper PM, Buxbaum JD, Kolevzon A. 2016. Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome. Journal of Neurodevelopmental Disorders 8:5. doi: 10.1186/s11689-016-9138-9
69. Wang X, Bey AL, Katz BM, Badea A, Kim N, David LK, Duffney LJ, Kumar S, Mague SD, Hulbert SW, Dutta N, Hayrapetyan V, Yu C, Gaidis E, Zhao S, Ding JD, Xu Q, Chung L, Rodriguiz RM, Wang F, et al. 2016. Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nature Communications 7:11459. doi: 10.1038/ncomms11459
70. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, Kim CJ, Berrios J, Colvin JS, Bousquet-Moore D, Lorenzo I, Wu G, Weinberg RJ, Ehlers MD, Philpot BD, Beaudet AL, Wetsel WC, Jiang YH. 2011. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Human Molecular Genetics 20: 3093–3108. doi: 10.1093/hmg/ddr212
71. Watson DJ, Loiseau F, Ingallinesi M, Millan MJ, Marsden CA, Fone KC. 2012. Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology 37:770–786. doi: 10.1038/npp.2011.254
72. Wiley RH. 2013. Specificity and multiplicity in the recognition of individuals: implications for the evolution of social behaviour. Biological Reviews 88:179–195. doi: 10.1111/j.1469-185X.2012.00246.x
73. Yang M, Bozdagi O, Scattoni ML, Wöhr M, Roullet FI, Katz AM, Abrams DN, Kalikhman D, Simon H, Woldeyohannes L, Zhang JY, Harris MJ, Saxena R, Silverman JL, Buxbaum JD, Crawley JN. 2012. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. Journal of Neuroscience 32:6525–6541. doi: 10.1523/JNEUROSCI.6107-11.2012
74. Yuen RK, Thiruvahindrapuram B, Merico D, Walker S, Tammimies K, Hoang N, Chrysler C, Nalpathamkalam T, Pellecchia G, Liu Y, Gazzellone MJ, D’Abate L, Deneault E, Howe JL, Liu RS, Thompson A, Zarrei M, Uddin M, Marshall CR, Ring RH, et al. 2015. Whole-genome sequencing of quartet families with autism spectrum disorder. Nature Medicine 21:185–191. doi: 10.1038/nm.3792